Roflumilast 250 ug/1

Roflumilast 250 ug tablets are a pharmaceutical product used for managing respiratory conditions. This oral medication is designed to help improve breathing and reduce inflammation in the lungs.

Roflumilast is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. Roflumilast tablets are often prescribed for long-term management of COPD, particularly in patients who experience frequent exacerbations.

Common effects of Roflumilast may include headache, diarrhea, nausea, and weight loss. Some users may also experience insomnia or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Roflumilast should be used with caution in patients with a history of mental health conditions, as it may increase the risk of mood changes. It is also important to inform your healthcare provider about any other medications you are taking, as Roflumilast may interact with certain drugs. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Roflumilast may interact with other medications, including those metabolized by the liver enzyme CYP3A4. It is important to avoid taking Roflumilast with strong CYP3A4 inducers or inhibitors, as this can affect the effectiveness of the medication. Additionally, alcohol should be avoided while taking Roflumilast, as it may increase the risk of side effects.